Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04452526 · ClinicalTrials.gov registry record · NA
I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination
A NA study of Cervical Carcinoma and Human Papillomavirus-Related Malignant Neoplasm, sponsored by Ohio State University Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 372
- Enrollment target
- 4
- Study locations
NCT04452526 is a NA study of Cervical Carcinoma and Human Papillomavirus-Related Malignant Neoplasm that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 372 participants, below the 521-participant average among 25 other Cervical Carcinoma trials with a reported enrollment target (29% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT04452526, a NA study of Cervical Carcinoma and Human Papillomavirus-Related Malignant Neoplasm, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 372 participants
- Enrollment target
- 4
- Study locations
Study Summary
This trial studies how well a multi-level health system-based intervention works in improving human papillomavirus (HPV) vaccine initiation and completion among children in health systems in four Appalachian states. Utilizing educational and promotional materials and electronic health record reminders, may improve the uptake of the HPV vaccine in children and young adults, ultimately preventing the development of cervical cancer.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Best Practice
- OTHER Educational Intervention
- OTHER Reminder
Study Locations (4)
Kentucky
- University of Kentucky/Markey Cancer Center - Lexington
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Virginia
- University of Virginia - Charlottesville
West Virginia
- West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 372 participants |
| Start Date | 2020-10-21 |
| Est. Completion | 2025-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04452526
The ClinicalTrials.gov registry entry for NCT04452526 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 372 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 521-participant average among 25 other Cervical Carcinoma trials with a reported enrollment target (29% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cervical Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT04452526 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Kentucky, Ohio, Virginia.
Frequently Asked Questions
What is clinical trial NCT04452526 about?
NCT04452526 is a clinical study titled "I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination". This trial studies how well a multi-level health system-based intervention works in improving human papillomavirus (HPV) vaccine initiation and completion among children in health systems in four Appalachian states. Utilizing educational and promotional materials and electronic health record reminde...
What is the current status of trial NCT04452526?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 372 participants. The study started on 2020-10-21. Estimated completion is 2025-09.
What conditions does trial NCT04452526 study?
This clinical trial studies the following conditions: Cervical Carcinoma, Human Papillomavirus-Related Malignant Neoplasm.
What interventions are being tested in trial NCT04452526?
The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Educational Intervention (OTHER), Reminder (OTHER).
Who is sponsoring clinical trial NCT04452526?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04452526 being conducted?
This trial has 4 study locations across Kentucky, Ohio, Virginia, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
RECRUITING · NA
-
The Ohio State University (OSU) SCREEN Community Program
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)
ACTIVE NOT RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Cervical Carcinoma
All registered trials for this condition
Human Papillomavirus-Related Malignant Neoplasm
All registered trials for this condition
Kentucky
All trials with a study site in Kentucky
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.